AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."

① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.

cls.cnApr 11 07:59 ET

12 Health Care Stocks Moving In Friday's Intraday Session

BenzingaApr 4 13:06 ET

U.S. stocks fluctuation | Regencell Bioscience (RGC.US) surged over 26% with a Market Cap of nearly 0.4 billion dollars.

On Friday, Regencell Bioscience (RGC.US) surged over 26%, reaching $30.70.

Zhitong FinanceApr 4 11:15 ET

Regencell Bioscience Holdings Ltd Trading Halted, Volatility Trading Pause

TipRanksApr 4 10:21 ET

Simulations Plus Posts Better-Than-Expected Results, Joins Savers Value Village, MarketAxess Holdings And Other Big Stocks Moving Higher On Friday

BenzingaApr 4 10:05 ET

NCino Posts Weak Earnings, Joins Tesla And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

BenzingaApr 2 07:32 ET